Genprex completes tech transfer for gene therapy to manufacturing
Genprex said that it has completed the technology transfer of the manufacturing process for its Reqorsa lead immunogene therapy candidate to commercial contract development and manufacturing organizations. Read More
Emulate says 'lung chips' to be used to study COVID-19
Emulate said that the U.S. Army will be using its Alveolus Lung-Chip technology to study the effects of the SARS-CoV-2 virus on human lung tissue. Read More
Lineage improves manufacturing of allogenic cell therapy product
Lineage Cell Therapeutics has provided an update for its OPC1 cell therapy program, an oligodendrocyte progenitor cell transplant for the treatment of acute spinal cord injuries. Read More
BioInnovation Institute thrives in Denmark
The Novo Nordisk Foundation has established the BioInnovation Institute as an independent foundation and will provide up to 470 million euros ($570 million U.S.) over the next 10 years to support early-stage life science projects and startups. Read More
NoveCite touts preclinical results of COVID-19 allogenic stem cell therapy
Citius Pharmaceuticals subsidiary NoveCite has released data from a proof-of-concept large animal study of its proprietary induced mesenchymal stem cell therapy for acute inflammatory respiratory conditions including acute respiratory distress syndrome related to COVID-19 disease. Read More
AstraZeneca, Qure.ai partner for lung cancer diagnosis
AstraZeneca has partnered with deep-learning algorithm developer Qure.ai to integrate artificial intelligence solutions for the early detection of lung cancer. Read More
Bayer, Atara collaborate on CAR T-cell therapies
Bayer and Atara Biotherapeutics have entered into an agreement to research, develop, manufacture, and license mesothelin-directed chimeric antigen receptor (CAR) T-cell therapies to treat solid tumors. Read More
Sherlock discovers novel CRISPR-associated enzymes
Sherlock Biosciences has announced the discovery of novel thermostable CRISPR-associated enzymes. Read More
MilliporeSigma invests $47M in U.S. biomanufacturing facilities
MilliporeSigma is increasing its manufacturing footprint in the U.S. with a $47 million investment in its Danvers, MA, and Jaffrey, NH, biomanufacturing facilities. Read More
Pfizer touts positive clinical data for bispecific antibody, gene therapy
Pfizer has announced safety and clinical response results from its ongoing phase I study of its bispecific antibody for multiple myeloma. The company also updated follow-up data from a phase I/II study of SB-525/PF-07055480 (giroctocogene fitelparvovec), an investigational gene therapy for patients with severe hemophilia A. Read More
Member Rewards
Earn points for contributing to market research. Redeem your points for merchandise, travel, or even to help your favorite charity.
Research Topics
Interact with an engaged, global community of your peers who come together to discuss their work and opportunities.
Connect
